MannKind Corporation (MNKD) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $3.90 (-2.63%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Aug 26, 2025 | Douglas Miehm | RBC Capital | $8.00 | +105.4% |
| Aug 28, 2024 | Steven Lichtman | Oppenheimer | $12.00 | +208.1% |
| Oct 10, 2023 | Andreas Argyrides | Wedbush | $10.00 | +156.7% |
Top Analysts Covering MNKD
MNKD vs Sector & Market
| Metric | MNKD | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.17 | 2.24 | 2.40 |
| Analyst Count | 12 | 8 | 19 |
| Target Upside | +130.7% | +11474.9% | +17.1% |
| P/E Ratio | 185.03 | 3.74 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $125M | $127M | $129M | 5 |
| 2027-03-31 | $125M | $128M | $129M | 3 |
| 2027-06-30 | $138M | $141M | $143M | 3 |
| 2027-09-30 | $144M | $147M | $149M | 3 |
| 2027-12-31 | $163M | $166M | $169M | 3 |
| 2028-03-31 | $113M | $115M | $116M | 2 |
| 2028-06-30 | $113M | $115M | $117M | 2 |
| 2028-09-30 | $243M | $248M | $251M | 2 |
| 2028-12-31 | $545M | $545M | $545M | 8 |
| 2029-12-31 | $510M | $613M | $657M | 7 |
| 2030-12-31 | $615M | $739M | $792M | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.01 | $-0.01 | $-0.01 | 1 |
| 2027-03-31 | $0.12 | $0.12 | $0.12 | 1 |
| 2027-06-30 | $0.14 | $0.14 | $0.14 | 1 |
| 2027-09-30 | $0.15 | $0.15 | $0.15 | 1 |
| 2027-12-31 | $-0.01 | $-0.01 | $-0.01 | 1 |
| 2028-03-31 | $0.02 | $0.02 | $0.02 | 1 |
| 2028-06-30 | $0.02 | $0.02 | $0.02 | 1 |
| 2028-09-30 | $0.24 | $0.25 | $0.25 | 1 |
| 2028-12-31 | $-0.14 | $0.10 | $0.30 | 7 |
| 2029-12-31 | $0.15 | $0.20 | $0.21 | 2 |
| 2030-12-31 | $0.31 | $0.40 | $0.44 | 5 |
Frequently Asked Questions
What is the analyst consensus for MNKD?
The consensus among 12 analysts covering MannKind Corporation (MNKD) is Buy with an average price target of $8.25.
What is the highest price target for MNKD?
The highest price target for MNKD is $12.00, set by Steven Lichtman at Oppenheimer on 2024-08-28.
What is the lowest price target for MNKD?
The lowest price target for MNKD is $8.00, set by Douglas Miehm at RBC Capital on 2025-08-26.
How many analysts cover MNKD?
12 analysts have issued ratings for MannKind Corporation in the past 12 months.
Is MNKD a buy or sell right now?
Based on 12 analyst ratings, MNKD has a consensus rating of Buy (2.17/5) with a +130.7% upside to the consensus target of $8.25.
What are the earnings estimates for MNKD?
Analysts estimate MNKD will report EPS of $-0.01 for the period ending 2026-12-31, with revenue estimated at $127M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.